Nuclear localization of PD-L1: artifact or reality? 2019

Hara Polioudaki, and Amanda Chantziou, and Konstantina Kalyvianaki, and Panagiotis Malamos, and George Notas, and Dimitris Mavroudis, and Marilena Kampa, and Elias Castanas, and Panayiotis A Theodoropoulos
Department of Biochemistry, School of Medicine, University of Crete, Voutes, 71013, Heraklion, Crete, Greece.

BACKGROUND The levels of expression and membrane localization of programmed cell death ligand 1 (PD-L1), an immune checkpoint type I transmembrane glycoprotein, are related to the clinical response of anti-PD-L1/PD-1 therapy. Although the biologically relevant localization of PD-L1 is on the plasma membrane of cancer cells, it has also been reported to be in the cytoplasm and sometimes in the nucleus. Furthermore, it has been claimed that chemotherapeutics can modify PD-L1 expression and/or its nuclear localization. RESULTS Data from our group suggest that the nuclear localization of PD-L1, and other plasma membrane proteins as well, could be an artifact resulting from inadequate experimental conditions during immunocytochemical studies. Mild detergent and rigorous fixation conditions should be used in order to preserve the membrane localization and to prevent an erroneous translocation of PD-L1 and other non-interconnected membrane proteins, such as CD24, into other cellular compartments including the nucleus, of untreated and chemotherapeutically treated breast cancer cells. CONCLUSIONS We propose that well-specified and rigorously followed protocols should be applied to immunocytochemical diagnostic techniques, especially to those related to individualized diagnosis and treatment.

UI MeSH Term Description Entries
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005260 Female Females
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016477 Artifacts Any visible result of a procedure which is caused by the procedure itself and not by the entity being analyzed. Common examples include histological structures introduced by tissue processing, radiographic images of structures that are not naturally present in living tissue, and products of chemical reactions that occur during analysis. Artefacts,Artefact,Artifact
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Hara Polioudaki, and Amanda Chantziou, and Konstantina Kalyvianaki, and Panagiotis Malamos, and George Notas, and Dimitris Mavroudis, and Marilena Kampa, and Elias Castanas, and Panayiotis A Theodoropoulos
December 2014, Expert opinion on emerging drugs,
Hara Polioudaki, and Amanda Chantziou, and Konstantina Kalyvianaki, and Panagiotis Malamos, and George Notas, and Dimitris Mavroudis, and Marilena Kampa, and Elias Castanas, and Panayiotis A Theodoropoulos
December 2012, Pain medicine (Malden, Mass.),
Hara Polioudaki, and Amanda Chantziou, and Konstantina Kalyvianaki, and Panagiotis Malamos, and George Notas, and Dimitris Mavroudis, and Marilena Kampa, and Elias Castanas, and Panayiotis A Theodoropoulos
January 2017, Blood,
Hara Polioudaki, and Amanda Chantziou, and Konstantina Kalyvianaki, and Panagiotis Malamos, and George Notas, and Dimitris Mavroudis, and Marilena Kampa, and Elias Castanas, and Panayiotis A Theodoropoulos
April 1979, Journal of child psychology and psychiatry, and allied disciplines,
Hara Polioudaki, and Amanda Chantziou, and Konstantina Kalyvianaki, and Panagiotis Malamos, and George Notas, and Dimitris Mavroudis, and Marilena Kampa, and Elias Castanas, and Panayiotis A Theodoropoulos
June 2023, International journal of molecular sciences,
Hara Polioudaki, and Amanda Chantziou, and Konstantina Kalyvianaki, and Panagiotis Malamos, and George Notas, and Dimitris Mavroudis, and Marilena Kampa, and Elias Castanas, and Panayiotis A Theodoropoulos
February 2024, Molecular oncology,
Hara Polioudaki, and Amanda Chantziou, and Konstantina Kalyvianaki, and Panagiotis Malamos, and George Notas, and Dimitris Mavroudis, and Marilena Kampa, and Elias Castanas, and Panayiotis A Theodoropoulos
September 2018, BMJ (Clinical research ed.),
Hara Polioudaki, and Amanda Chantziou, and Konstantina Kalyvianaki, and Panagiotis Malamos, and George Notas, and Dimitris Mavroudis, and Marilena Kampa, and Elias Castanas, and Panayiotis A Theodoropoulos
October 1982, FEBS letters,
Hara Polioudaki, and Amanda Chantziou, and Konstantina Kalyvianaki, and Panagiotis Malamos, and George Notas, and Dimitris Mavroudis, and Marilena Kampa, and Elias Castanas, and Panayiotis A Theodoropoulos
September 1996, Radiology,
Hara Polioudaki, and Amanda Chantziou, and Konstantina Kalyvianaki, and Panagiotis Malamos, and George Notas, and Dimitris Mavroudis, and Marilena Kampa, and Elias Castanas, and Panayiotis A Theodoropoulos
January 2020, European journal of applied physiology,
Copied contents to your clipboard!